Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.750
-0.070 (-3.85%)
At close: Nov 19, 2025, 4:00 PM EST
1.680
-0.070 (-4.00%)
After-hours: Nov 19, 2025, 4:31 PM EST
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $66.09 million as of November 19, 2025. Its market cap has increased by 128.30% in one year.
Market Cap
66.09M
Enterprise Value
67.11M
1-Year Change
128.30%
Ranking
Category
Stock Price
$1.75
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $66.09M, an increase of 3,617.92%. That is a compound annual growth rate of 223.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 70.24M | 61.80% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 913.81B |
| Johnson & Johnson | 476.03B |
| AbbVie | 414.22B |
| UnitedHealth Group | 293.65B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 231.00B |
| Abbott Laboratories | 228.05B |